Showing results (5611-5620 of 10,388) with videos related to
Sort By:
Pageof 1,039
Vaccines|July 27, 2022
mRNA Booster Vaccination Enhances Antibody Responses against SARS-CoV2 Omicron Variant in Individuals Primed with mRNA or Inactivated Virus VaccinesBiyan Zhang, Jianxin Huo, Yuhan Huang, et al.Vaccines|July 27, 2022
Students as Community Vaccinators: Implementation of A Service-Learning COVID-19 Vaccination ProgramAndrew R Griswold, Julia Klein, Neville Dusaj, et al.Vaccines|July 27, 2022
Predictors of Willingness of the General Public to Receive a Second COVID-19 Booster Dose or a New COVID-19 Vaccine: A Cross-Sectional Study in GreecePetros Galanis, Irene Vraka, Aglaia Katsiroumpa, et al.Vaccines|July 27, 2022
Durability of Humoral and Cellular Immunity after an Extended Primary Series with Heterologous Inactivated SARS-CoV-2 Prime-Boost and ChAdOx1 nCoV-19 in Dialysis Patients (ICON3)Sarinya Boongird, Chavachol Setthaudom, Rungthiwa Kitpermkiat, et al.Vaccines|July 27, 2022
Rare Adverse Events Associated with BNT162b2 mRNA Vaccine (Pfizer-BioNTech): A Review of Large-Scale, Controlled Surveillance StudiesShin-Jie Yong, Alice Halim, Michael Halim, et al.Vaccines|July 27, 2022
Neutralizing Antibodies to Human Cytomegalovirus Recombinant Proteins Reduce Infection in an Ex Vivo Model of Developing Human PlacentasTakako Tabata, Matthew Petitt, Julia Li, et al.Vaccines|July 27, 2022
Determinants of COVID-19 Vaccine Uptake and Acceptability in the Horn of Africa: Evidence from SomalilandSaed A Sulub, Mubarak A MohamedVaccines|July 27, 2022
Effects of Different Biological Therapies on S1/S2 Antibody Response to SARS-CoV-2 Vaccination in a Cohort of Patients with Inflammatory Bowel DiseaseNunzia Labarile, Fabio Castellana, Annamaria Sila, et al.Vaccines|July 27, 2022
Three Separate Spike Antigen Exposures by COVID-19 Vaccination or SARS-CoV-2 Infection Elicit Strong Humoral Immune Responses in Healthcare WorkersThomas Theo Brehm, Felix Ullrich, Michelle Thompson, et al.Vaccines|July 27, 2022
Adverse Events of Vaccination against Hepatitis B Virus in Post-Marketing Surveillance from 2005 to 2017 in Guangdong Province, ChinaYu Liu, Minyi Zhang, Meiling Yang, et al.Pageof 1,039